Identification of Aminothienopyridazine Inhibitors of Tau Assembly by Quantitative High-Throughput Screening

被引:85
作者
Crowe, Alex [1 ,2 ]
Huang, Wenwei [4 ]
Ballatore, Carlo [1 ,2 ,3 ]
Johnson, Ronald L. [4 ]
Hogan, Anne-Marie L. [3 ]
Huang, Ruili [4 ]
Wichterman, Jennifer [4 ]
McCoy, Joshua [4 ]
Huryn, Donna [3 ]
Auld, Douglas S. [4 ]
Smith, Amos B., III [3 ]
Inglese, James [4 ]
Trojanowski, John Q. [1 ,2 ]
Austin, Christopher P. [4 ]
Brunden, Kurt R. [1 ,2 ]
Lee, Virginia M. -Y. [1 ,2 ]
机构
[1] Univ Penn, Sch Med, Inst Aging, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Arts & Sci, Dept Chem, Philadelphia, PA 19104 USA
[4] NIH, Chem Genom Ctr, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
MICROTUBULE-ASSOCIATED PROTEIN; FIBRILLIZATION IN-VITRO; ALZHEIMERS-DISEASE; NEURODEGENERATIVE TAUOPATHIES; PHOSPHORYLATED-TAU; PURIFIED TUBULIN; AGGREGATION; IMPAIRMENTS; DISORDERS; FILAMENTS;
D O I
10.1021/bi9006435
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inclusions comprised of fibrils of the microtubule- (MT-) associated protein tau are found in the brains of those with Alzheimer's disease (AD) and other neurodegenerative tauopathies. The pathology that is observed in these diseases is believed to result from the formation of toxic tau oligomers or fibrils and/or from the loss of normal tau function due to its sequestration into insoluble deposits. Hence, small molecules that prevent tau oligomerization and/or fibrillization might have therapeutic value. Indeed, examples of such compounds have been published, but nearly all have properties that render them unsuitable as drug candidates. For these reasons, we conducted quantitative high-throughput screening (qHTS) of similar to 292000 compounds to identify drug-like inhibitors of tau assembly. The fibrillization of a truncated tau fragment that contains Four MT-binding domains was monitored in an assay that employed complementary thioflavin T fluorescence and fluorescence polarization methods. Previously described classes of inhibitors as well as new scaffolds were identified, including novel aminothienopyridazines (ATPZs). A number of ATPZ analogues were synthesized, and structure-activity relationships were defined. Further characterization of representative ATPZ compounds showed they do not interfere with tau-mediated MT assembly, and they are significantly more effective at preventing the fibrillization of tau than the A beta(1-42) peptide which forms AD senile plaques. Thus, the ATPZ molecules described here represent a novel class of tau assembly inhibitors that merit further development for testing in animal models of AD-like tau pathology.
引用
收藏
页码:7732 / 7745
页数:14
相关论文
共 61 条
[51]   Tau suppression in a neurodegenerative mouse model improves memory function [J].
SantaCruz, K ;
Lewis, J ;
Spires, T ;
Paulson, J ;
Kotilinek, L ;
Ingelsson, M ;
Guimaraes, A ;
DeTure, M ;
Ramsden, M ;
McGowan, E ;
Forster, C ;
Yue, M ;
Orne, J ;
Janus, C ;
Mariash, A ;
Kuskowski, M ;
Hyman, B ;
Hutton, M ;
Ashe, KH .
SCIENCE, 2005, 309 (5733) :476-481
[52]   Malonate-assisted purification of human caspases [J].
Scheer, JM ;
Wells, JA ;
Romanowski, MJ .
PROTEIN EXPRESSION AND PURIFICATION, 2005, 41 (01) :148-153
[53]   Expression, preparation, and high-throughput screening of caspase-8: Discovery of redox-based and steroid diacid inhibition [J].
Smith, GK ;
Barrett, DG ;
Blackburn, K ;
Cory, M ;
Dallas, WS ;
Davis, R ;
Hassler, D ;
McConnell, R ;
Moyer, M ;
Weaver, K .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 399 (02) :195-205
[54]   Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins [J].
Taniguchi, S ;
Suzuki, N ;
Masuda, M ;
Hisanaga, S ;
Iwatsubo, T ;
Goedert, M ;
Hasegawa, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (09) :7614-7623
[55]   Microtubule-stabilising drugs for therapy of Alzheimer's disease and other neurodegenerative disorders with axonal transport impairments [J].
Trojanowski, JQ ;
Smith, AB ;
Huryn, D ;
Lee, VMY .
EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (05) :683-686
[56]  
Wagner U, 1996, J CELL SCI, V109, P1537
[57]   PLAQUES, TANGLES AND DEMENTIA - A QUANTITATIVE STUDY [J].
WILCOCK, GK ;
ESIRI, MM .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1982, 56 (2-3) :343-356
[58]  
Wilson DM, 1997, AM J PATHOL, V150, P2181
[59]   Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines [J].
Wischik, CM ;
Edwards, PC ;
Lai, RYK ;
Roth, M ;
Harrington, CR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :11213-11218
[60]   Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model [J].
Zhang, B ;
Maiti, A ;
Shively, S ;
Lakhani, F ;
McDonald-Jones, G ;
Bruce, J ;
Lee, EB ;
Xie, SX ;
Joyce, S ;
Li, C ;
Toleikis, PM ;
Lee, VMY ;
Trojanowski, JQ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (01) :227-231